PerioTrap launches soft launch in Halle

With this soft launch, the biotech company is taking a decisive step toward market entry, introducing two innovative products designed to help prevent periodontitis:

• PerioTrap Prophylaxis-Gel for professional use in dental practices
• PerioTrap Microbiome Toothpaste for daily care at home

Both products combine cutting-edge science with everyday practicality and represent a paradigm shift in gum care: instead of non-specific germ reduction, PerioTrap® technology focuses on targeted microbiome modulation.

From Alzheimer’s research to dentistry – a breakthrough discovery

What started as research in the field of Alzheimer’s therapy led to a groundbreaking discovery for dentistry. The patented active substance S-636 specifically blocks harmful bacteria such as Porphyromonas gingivalis – the main cause of periodontitis – without disturbing the delicate balance of the oral microbiome.

“With the soft launch in Halle, we are closing the circle – from lab research to the first tube”, says Dr. Mirko Buchholz, Co-Founder and CSO von PerioTrap. “We are proud to launch our technology right here, where it was developed.”

A new approach to gum care

For decades, periodontitis treatment has changed very little: chlorhexidine and antibiotics remain the most common options, despite their well-known downsides.

“The concept has to evolve”, emphasizes Dr. James Belcher, dentist and Product Manager at PerioTrap. “What fluoride did for cavity prevention in the 1970s, the PerioTrap® technology can now achieve for gum health.”
The vision: tackling periodontitis at its root without harming the beneficial bacteria – a completely new way of thinking in modern dentistry.

Exclusive launch in Halle and online

The new products are currently available exclusively at St. Georg Pharmacy in Halle (Saale) and through its online shop at apozilla.de.
A broader market launch is planned for September 2025.

Find out more here: oralcare.periotrap.com